Stephanos Lambropoulos MEDICAL ONCOLOGY Associate Director, 3rd Internal Medicine – Oncology Clinic

• American College of Physicians
• American Society of Hematology
• American Society of Clinical Oncology
• Greek Medical Oncology Society
• European Society of Medical Oncology
• Athens Medical Association

• 1990-1991: 251 General Air Force Hospital, Athens, Greece, Medical Internship 
• 1991-1992: Social Service, Primary care in rural Messinia, Greece
• 1992-1995: University of Illinois at Chicago, Residency in Internal Medicine
• 1995-1998: University of Minnesota, Minneapolis, Fellowship in Hematology Oncology and Transplantation

Research:

• Molecular Biology, Regulation of globin gene expression during Embryogenesis, Fungal infections during BMT
• 998-1999, Virginia Commonwealth University / Massey Cancer Center Virginia, Fellowship in Hematology and Medical Oncology

Research:

• Generation of transgenic mice for the study of regulation of globin gene family during embryogenesis
• 2000 – Today, Hygeia General Hospital, Athens Greece, Associate Director, 3rd Department of Medical Oncology

Research:

• Medical Oncology – epigenetics

Clinical Interest:

• Medical Oncology
• Hematology

Research Interest:

• “Good Clinical Practice for Investigational Site Staff 2.0” training. April 14, 2015 
• Sub-Investigator in Phase II HE42/09 brain metastases from lung and breast study (2009 – 2014)
• Sub-Investigator in Phase II HE11B/11 breast cancer study (2011 – ongoing)

• Scientific resident of the year, annual awards University of Illinois, Chicago
• Award by the University of Addis Ababa, Ethiopia for voluntary work in May 2007 

• Breast cancer chapter in: Advancements in Internal Medicine publication ZHTA. 2001 and 2006 (in Greek)
• Geriatric Oncology in: Basic principles of Cancer Treatment, edition 2006 (Greek)
• Geriatric treatment of Breast cancer in: Breast Cancer, edition 2007 (Greek)
• Immunologic therapy of cancer in: Pathology of the Lymphatic System, Athens 2011

• MBD2 contributes to developmental silencing of the human ε-globin gene. Blood Cells Mol Dis. 2011 Mar 15; 46(3):212-9. doi: 10.1016/j.bcmd.2011.01.001. Epub 2011 Feb 4.
• Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib – A case report with clinical implications. O.Nikolatou-Galitis, E.Razis, D.Galiti, E.Vardas, F.Tzerbos, S.Labropoulos. FCO, 2013; 4:4:29-33.
• Periodontal tissue involvement preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: Report of 5 cases and literature review. O.Nicolatou-Galitis; E.Razis; D.Galiti; E.Galitis; S.Labropoulos; A.Tsimpidakis; J.Sgouros; A.Karamepazis; C.A.Migliorati. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology. doi: 10.1016/j.oooo.2015.08.007.
• Unusual mandibular metastasis of bladder cancer in a patient and two synchronous malignancies, bladder cancer and chronic lymphocytic leukemia, in a single lymph node. A case report. C.Liakou, M.Georgiou, T.Georgiadis, G.Rigakos, S. Lampropoulos, E.Razis. Case Reports in Clinical Pathology, 2015, Vol. 2, No. 4.
• Extracranial and diffuse bone marrow metastases from Anaplastic Oligodendroglioma: a case report and review of the literature. A.Assi, A.Huang, G.Rigakos, S.Papadopoulos, Th.Georgiadis, E.Vrakidou, C.Dardoufas, S.Lampropoulos, P.Nomikos, E.Razis. Neuro-Oncology Practice (submitted 2016).